Velnex Bioceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 10 Months
- Last Filing with ROC 31 Mar 2021
- Revenue Growth -27.36%
- Profit Growth 98.58%
- Ebitda 139.70%
- Net Worth 51.99%
- Total Assets -8.76%
About Velnex Bioceuticals
Velnex Bioceuticals Private Limited (VBPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 April 2017 (Seven years and ten months 10 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Manoj Sehgal and Alok Sharma serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51909DL2017PTC316200
- Company No.
316200
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Apr 2017
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
What products or services does Velnex Bioceuticals Private Limited offer?
Velnex Bioceuticals Private Limited offers a wide range of products and services, including Common Disease Medicines, Antihistamines, TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Pain Relief Drugs & Pharmaceuticals, Anti Inflammatory Drugs.
Who are the key members and board of directors at Velnex Bioceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manoj Sehgal  | Director | 17-Apr-2017 | Current |
| Alok Sharma | Director | 17-Apr-2017 | Current |
Financial Performance of Velnex Bioceuticals.
Velnex Bioceuticals Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 27.36% decrease. The company also saw a substantial improvement in profitability, with a 98.58% increase in profit. The company's net worth Soared by an impressive increase of 51.99%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Velnex Bioceuticals?
Unlock access to Velnex Bioceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Jessant Lifesciences Private LimitedManoj Sehgal is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Velnex Bioceuticals?
Unlock and access historical data on people associated with Velnex Bioceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Velnex Bioceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Velnex Bioceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
